Neuronal and Astrocyte Insulin-like Growth Factor-1 Signaling Differentially Modulates Ischemic Stroke Damage

Ischemic stroke is a leading cause of death and disability, as therapeutic options for mitigating the long-term deficits precipitated by the event remain limited. Acute administration of the neuroendocrine modulator insulin-like growth factor-1 (IGF-1) attenuates ischemic stroke damage in preclinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayes, Cellas A., Morgan, Nyah I., Thomas, Kamryn C., Pushie, M. Jake., Vijayasankar, Akshaya, Ashmore, Brandon G., Wontor, Kendall, De Leon, Miguel A., Ashpole, Nicole M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081310/
https://www.ncbi.nlm.nih.gov/pubmed/37034764
http://dx.doi.org/10.1101/2023.04.02.535245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081310/
https://www.ncbi.nlm.nih.gov/pubmed/37034764
http://dx.doi.org/10.1101/2023.04.02.535245

Ejemplares similares